Neurogenin 3 is important but not essential for pancreatic islet development in humans

Diabetologia

Volumn 57, Issue 11, 2014, Pages 2421-2424

  Rubio Cabezas, Oscar ^a   Codner, Ethel ^b   Flanagan, Sarah E ^c   Gómez, José L ^d   Ellard, Sian ^c   Hattersley, Andrew T ^c  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^d HOSPITAL TORRECÁRDENAS   (Spain)

Author keywords

Diabetes; Enteric anendocrinosis; Islet development; Neonatal diabetes; Neurogenin 3

Indexed keywords

C PEPTIDE; CHOLECYSTOKININ; GENOMIC DNA; GLUCAGON LIKE PEPTIDE 1; INSULIN; NEUROGENIN 3; SECRETIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; NERVE PROTEIN; NEUROG3 PROTEIN, HUMAN;

CELL DIFFERENTIATION; CLINICAL FEATURE; CONCEPTION; ENDOCRINE FUNCTION; ENTEROENDOCRINE CELL; FETUS DEVELOPMENT; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOTE; HUMAN; INSULIN RELEASE; INTESTINAL FAILURE; INTESTINE BIOPSY; LETTER; LONG TERM CARE; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; NONHUMAN; PANCREAS ISLET; PANCREAS SECRETION; PARENTERAL NUTRITION; STEM CELL; TRANSIENT EXPRESSION; ADOLESCENT; ADULT; GENETICS; METABOLISM; MUTATION; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; HUMANS; ISLETS OF LANGERHANS; MUTATION; NERVE TISSUE PROTEINS; YOUNG ADULT;

EID: 84920007999     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3349-y     Document Type: Letter

References (12)

1. Gradwohl G, Dierich A, LeMeur M, Guillemot F (2000) neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci U S A 97:1607–1611
2. Jenny M, Uhl C, Roche C et al (2002) Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21:6338–6347
3. Rukstalis JM, Habener JF (2009) Neurogenin3: a master regulator of pancreatic islet differentiation and regeneration. Islets 1:177–184
4. Lyttle BM, Li J, Krishnamurthy M et al (2008) Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia 51:1169–1180
5. Jennings RE, Berry AA, Kirkwood-Wilson R et al (2013) Development of the human pancreas from foregut to endocrine commitment. Diabetes 62:3514–3522
6. Wang J, Cortina G, Wu SV et al (2006) Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med 355:270–280
7. Jensen JN, Rosenberg LC, Hecksher-Sørensen J, Serup P (2007) Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med 356:1781–1782
8. Rubio-Cabezas O, Jensen JN, Hodgson MI et al (2011) Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3. Diabetes 60:1349–1353
9. Pinney SE, Oliver-Krasinski J, Ernst L et al (2011) Neonatal diabetes and congenital malabsorptive diarrhea attributable to a novel mutation in the human neurogenin-3 gene coding sequence. J Clin Endocrinol Metab 96:1960–1965
10. Sayar E, Islek A, Yilmaz A, Akcam M, Flanagan SE, Artan R (2013) Extremely rare cause of congenital diarrhea: enteric anendocrinosis. Pediatr Int 55:661–663
11. Ohsie S, Gerney G, Gui D, Kahana D, Martín MG, Cortina G (2009) A paucity of colonic enteroendocrine and/or enterochromaffin cells characterizes a subset of patients with chronic unexplained diarrhea/malabsorption. Hum Pathol 40:1006–1014
12. Flasse LC, Pirson JL, Stern DG et al (2013) Ascl1b and Neurod1, instead of Neurog3, control pancreatic endocrine cell fate in zebrafish. BMC Biol 11:78